🇺🇸 ABBV — AbbVie Inc.

Healthcare Compra
← Volver

Precio actual

256,46 USD

Máx. histórico

267,47

37 días

Caída desde máximo

-4,12%

Rango 52 semanas

190,75 – 267,47

Variación hoy

-1,44%

Cierre anterior

260,21

Rango de hoy

255,61 – 258,91

Volumen hoy

4.701.126

Información
Nombre completo
AbbVie Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
57.000
PER ⓘ
72,45 (puede no estar actualizado)
Dividend yield
2,70% (puede no estar actualizado)
Precio objetivo analistas
276,59 USD (puede no estar actualizado)
Primera cotización
02/01/2013
Precio actualizado
hace 1 día
Sobre la empresa

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Dividendos repartidos Total últimos 12 meses: 6,8300 USD · Yield: 2,66%
Fecha de pago Importe por participación
13/04/2015 0,5100 USD
13/01/2015 0,4900 USD
10/10/2014 0,4200 USD
11/07/2014 0,4200 USD
11/04/2014 0,4200 USD
13/01/2014 0,4000 USD
10/10/2013 0,4000 USD
11/07/2013 0,4000 USD
11/04/2013 0,4000 USD
11/01/2013 0,4000 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/09/2015 59,43 59,62 57,54 58,94 -0,69% 3,50% 9.095.600
11/09/2015 59,62 59,76 58,97 59,35 -0,39% 1,33% 9.365.400
10/09/2015 59,36 60,13 58,89 59,58 +0,54% 2,09% 9.306.600
09/09/2015 61,52 61,52 59,11 59,26 -2,16% 3,92% 8.436.900
08/09/2015 60,22 60,94 59,91 60,57 +1,34% 1,71% 9.263.200
04/09/2015 60,65 60,80 58,96 59,77 -2,94% 3,03% 9.281.400
03/09/2015 61,45 62,28 61,35 61,58 +0,98% 1,51% 11.777.400
02/09/2015 61,56 61,60 60,28 60,98 +0,79% 2,14% 12.044.500
01/09/2015 61,00 61,63 60,16 60,50 -3,06% 2,41% 12.703.200
31/08/2015 64,14 64,31 62,25 62,41 -2,45% 3,21% 15.581.100
28/08/2015 63,91 64,78 63,44 63,98 -0,82% 2,10% 7.316.400
27/08/2015 64,03 64,60 63,00 64,51 +2,17% 2,50% 12.592.100
26/08/2015 62,47 63,22 60,88 63,14 +4,00% 3,75% 15.289.600
25/08/2015 65,11 65,12 60,65 60,71 -4,32% 6,87% 15.267.000
24/08/2015 61,17 64,85 53,87 63,45 -3,72% 17,95% 24.292.600
21/08/2015 66,74 67,16 65,83 65,90 -2,34% 1,99% 16.277.100
20/08/2015 68,00 68,43 67,48 67,48 -1,62% 1,40% 9.600.900
19/08/2015 68,75 69,08 68,21 68,59 -0,39% 1,27% 6.270.300
18/08/2015 69,42 69,74 68,67 68,86 -0,74% 1,54% 6.376.500
17/08/2015 68,71 69,82 68,30 69,37 +1,05% 2,21% 17.669.900
14/08/2015 68,56 69,44 68,41 68,65 +0,16% 1,50% 5.864.800
13/08/2015 68,68 69,09 68,21 68,54 -0,31% 1,28% 7.184.900
12/08/2015 67,83 68,92 67,24 68,75 +0,73% 2,48% 8.337.600
11/08/2015 68,50 69,29 67,94 68,25 -1,39% 1,97% 7.473.200
10/08/2015 68,92 69,43 68,50 69,21 +0,86% 1,35% 8.189.400
07/08/2015 69,08 69,30 67,77 68,62 -0,90% 2,21% 6.214.500
06/08/2015 70,37 70,78 68,80 69,24 -1,51% 2,81% 6.172.200
05/08/2015 70,10 70,64 70,05 70,30 +0,50% 0,84% 10.090.200
04/08/2015 70,04 70,39 69,67 69,95 +0,32% 1,03% 5.410.900
03/08/2015 70,19 70,79 69,28 69,73 -0,40% 2,15% 9.872.300